Shenzhen King Explorer Science and Technology Corporation
SZSE:002917.SZ
9.25 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,507.269 | 1,192.995 | 815.11 | 633.044 | 451.561 | 418.463 | 431.938 | 456.121 | 398.957 | 319.842 | 206.909 |
| Cost of Revenue
| 1,021.587 | 871.963 | 605.429 | 433.972 | 282.886 | 256.272 | 279.789 | 303.354 | 260.912 | 221.23 | 147.316 |
| Gross Profit
| 485.682 | 321.032 | 209.681 | 199.072 | 168.675 | 162.191 | 152.149 | 152.767 | 138.045 | 98.611 | 59.593 |
| Gross Profit Ratio
| 0.322 | 0.269 | 0.257 | 0.314 | 0.374 | 0.388 | 0.352 | 0.335 | 0.346 | 0.308 | 0.288 |
| Reseach & Development Expenses
| 79.35 | 76.451 | 56.241 | 45.209 | 33.516 | 28.772 | 24.506 | 25.35 | 17.647 | 14.673 | 9.52 |
| General & Administrative Expenses
| 51.223 | 48.683 | 28.601 | 16.685 | 10.734 | 14.025 | 8.191 | 9.381 | 21.074 | 8.755 | 29.969 |
| Selling & Marketing Expenses
| 77.263 | 44.946 | 21.563 | 19.743 | 26.97 | 22.143 | 19.893 | 19.398 | 18.964 | 15.219 | 8.768 |
| SG&A
| 128.486 | 93.628 | 50.164 | 36.427 | 37.704 | 36.168 | 28.083 | 28.779 | 40.038 | 23.974 | 38.736 |
| Other Expenses
| -1,390.286 | 113.863 | 59.444 | 35.828 | 25.651 | 0.094 | 3.537 | 8.176 | 2.441 | 0.374 | 0.459 |
| Operating Expenses
| 1,390.286 | 283.942 | 165.849 | 117.464 | 96.872 | 88.006 | 72.109 | 77.635 | 81.107 | 54.112 | 39.351 |
| Operating Income
| 116.984 | 62.391 | 53.846 | 83.953 | 79.703 | 84.001 | 81.868 | 76.034 | 91.075 | 38.241 | 19.413 |
| Operating Income Ratio
| 0.078 | 0.052 | 0.066 | 0.133 | 0.177 | 0.201 | 0.19 | 0.167 | 0.228 | 0.12 | 0.094 |
| Total Other Income Expenses Net
| 0.112 | -82.014 | -24.479 | -0.108 | -0.056 | 9.91 | 5.366 | 8.958 | 36.569 | -5.892 | -0.369 |
| Income Before Tax
| 117.095 | -19.623 | 29.367 | 83.845 | 79.647 | 84.094 | 85.406 | 84.09 | 93.508 | 38.607 | 19.872 |
| Income Before Tax Ratio
| 0.078 | -0.016 | 0.036 | 0.132 | 0.176 | 0.201 | 0.198 | 0.184 | 0.234 | 0.121 | 0.096 |
| Income Tax Expense
| 9.88 | 0.629 | -2.637 | 7.146 | 8.631 | 12.587 | 14.097 | 13.9 | 17.328 | 6.179 | 4.266 |
| Net Income
| 101.663 | -20.252 | 39.9 | 68.523 | 61.274 | 65.114 | 62.517 | 61.774 | 72.526 | 29.049 | 14.484 |
| Net Income Ratio
| 0.067 | -0.017 | 0.049 | 0.108 | 0.136 | 0.156 | 0.145 | 0.135 | 0.182 | 0.091 | 0.07 |
| EPS
| 0.29 | -0.059 | 0.15 | 0.25 | 0.23 | 0.24 | 0.31 | 0.41 | 5.49 | 2.42 | 0.097 |
| EPS Diluted
| 0.29 | -0.059 | 0.15 | 0.25 | 0.23 | 0.24 | 0.31 | 0.41 | 5.49 | 2.42 | 0.097 |
| EBITDA
| 266.642 | 145.289 | 99.127 | 108.258 | 83.995 | 82.463 | 86.308 | 80.913 | 61.314 | 50.513 | 21.686 |
| EBITDA Ratio
| 0.177 | 0.122 | 0.122 | 0.171 | 0.186 | 0.197 | 0.2 | 0.177 | 0.154 | 0.158 | 0.105 |